SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Drugs gets EIR from USFDA for Maharashtra API manufacturing facility

24 Dec 2024 Evaluate

Aarti Drugs has received Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for its API manufacturing facility located at MIDC, Tarapur, Maharashtra. 

In September 2024, USFDA had concluded inspection at said facility. On conclusion of the inspection, the company had received 7 inspectional observations in Form 483, where none of the observations are related to Data Integrity. 

Aarti Drugs is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary - Pinnacle Life Science.

Aarti Drugs Share Price

388.45 -9.30 (-2.34%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×